Pharmaceutical practice of clinical pharmacists participating in the treatment for refractory edema secondary to diabetic kidney disease
10.19960/j.issn.1005-0698.202312013
- VernacularTitle:临床药师参与1例糖尿病肾病继发难治性水肿患者治疗的药学实践
- Author:
Ze CHEN
1
,
2
;
Wei TIAN
;
Qi JIN
;
Xian-Xi GUO
;
Hua HU
Author Information
1. 武汉大学人民医院药学部(武汉 430060)
2. 中国人民解放军中部战区总医院药剂科(武汉 430070)
- Keywords:
Clinical pharmacist;
Drug treatment;
Diabetic kidney disease;
Refractory edema;
Pharmaceutical care
- From:
Chinese Journal of Pharmacoepidemiology
2023;32(12):1425-1431
- CountryChina
- Language:Chinese
-
Abstract:
Clinical pharmacist participated in the whole process of combined drug treatment and medication monitoring of a patient with refractory edema secondary to end-stage diabetic kidney disease.By using dapagliflozin combined with sacubitril valsartan and conventional diuretics,the patient's body weight decreased by 16 kg,blood pressure returned to normal,systemic edema subsided and the symptoms of heart failure obviously improved.In this case,clinical pharmacist provided individualized pharmaceutical care and assisted clinicians to make a scientific and reasonable drug therapy,so as to provide a new idea and medication reference for clinical patients to delay the time of renal replacement therapy.
